These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31647875)

  • 1. Design, Synthesis, and Biological Evaluation of Novel Indoles Targeting the Influenza PB2 Cap Binding Region.
    McGowan DC; Balemans W; Embrechts W; Motte M; Keown JR; Buyck C; Corbera J; Funes M; Moreno L; Cooymans L; Tahri A; Eymard J; Stoops B; Strijbos R; Van den Berg J; Fodor E; Grimes JM; Koul A; Jonckers THM; Raboisson P; Guillemont J
    J Med Chem; 2019 Nov; 62(21):9680-9690. PubMed ID: 31647875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methyl brevifolincarboxylate, a novel influenza virus PB2 inhibitor from Canarium Album (Lour.) Raeusch.
    Chen F; Yang L; Zhai L; Huang Y; Chen F; Duan W; Yang J
    Chem Biol Drug Des; 2020 Nov; 96(5):1280-1291. PubMed ID: 32519462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2.
    Clark MP; Ledeboer MW; Davies I; Byrn RA; Jones SM; Perola E; Tsai A; Jacobs M; Nti-Addae K; Bandarage UK; Boyd MJ; Bethiel RS; Court JJ; Deng H; Duffy JP; Dorsch WA; Farmer LJ; Gao H; Gu W; Jackson K; Jacobs DH; Kennedy JM; Ledford B; Liang J; Maltais F; Murcko M; Wang T; Wannamaker MW; Bennett HB; Leeman JR; McNeil C; Taylor WP; Memmott C; Jiang M; Rijnbrand R; Bral C; Germann U; Nezami A; Zhang Y; Salituro FG; Bennani YL; Charifson PS
    J Med Chem; 2014 Aug; 57(15):6668-78. PubMed ID: 25019388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Ranking System for Identifying Efficacious Anti-Influenza Virus PB2 Inhibitors.
    Tsai AW; McNeil CF; Leeman JR; Bennett HB; Nti-Addae K; Huang C; Germann UA; Byrn RA; Berlioz-Seux F; Rijnbrand R; Clark MP; Charifson PS; Jones SM
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6007-16. PubMed ID: 26169418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Small-Molecule Compound Has Anti-influenza A Virus Activity by Acting as a ''PB2 Inhibitor".
    Liu T; Liu M; Chen F; Chen F; Tian Y; Huang Q; Liu S; Yang J
    Mol Pharm; 2018 Sep; 15(9):4110-4120. PubMed ID: 30102858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superior inhibition of influenza virus hemagglutinin-mediated fusion by indole-substituted spirothiazolidinones.
    Cihan-Üstündağ G; Zopun M; Vanderlinden E; Ozkirimli E; Persoons L; Çapan G; Naesens L
    Bioorg Med Chem; 2020 Jan; 28(1):115130. PubMed ID: 31753804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of BPR3P0128 as an inhibitor of cap-snatching activities of influenza virus.
    Hsu JT; Yeh JY; Lin TJ; Li ML; Wu MS; Hsieh CF; Chou YC; Tang WF; Lau KS; Hung HC; Fang MY; Ko S; Hsieh HP; Horng JT
    Antimicrob Agents Chemother; 2012 Feb; 56(2):647-57. PubMed ID: 21930871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of novel potent orally bioavailable oseltamivir derivatives active against resistant influenza A.
    Schade D; Kotthaus J; Riebling L; Kotthaus J; Müller-Fielitz H; Raasch W; Koch O; Seidel N; Schmidtke M; Clement B
    J Med Chem; 2014 Feb; 57(3):759-69. PubMed ID: 24422530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isosteric replacements of the carboxylic acid of drug candidate VX-787: Effect of charge on antiviral potency and kinase activity of azaindole-based influenza PB2 inhibitors.
    Boyd MJ; Bandarage UK; Bennett H; Byrn RR; Davies I; Gu W; Jacobs M; Ledeboer MW; Ledford B; Leeman JR; Perola E; Wang T; Bennani Y; Clark MP; Charifson PS
    Bioorg Med Chem Lett; 2015 May; 25(9):1990-4. PubMed ID: 25827523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral Activity of 3D, a Butene Lactone Derivative Against Influenza A Virus In Vitro and In Vivo.
    Wang Z; Fang J; Luo J; Hou D; Tan Y; Gu Z; Ge Y; Mao L; Liu L; Liu H; Wei Z; Xu H
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33670217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-influenza virus activity of benzo[d]thiazoles that target heat shock protein 90.
    Lamut A; Gjorgjieva M; Naesens L; Liekens S; Lillsunde KE; Tammela P; Kikelj D; Tomašič T
    Bioorg Chem; 2020 May; 98():103733. PubMed ID: 32171985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis.
    Vanderlinden E; Vrancken B; Van Houdt J; Rajwanshi VK; Gillemot S; Andrei G; Lemey P; Naesens L
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6679-6691. PubMed ID: 27572398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase.
    Ding Y; Dou J; Teng Z; Yu J; Wang T; Lu N; Wang H; Zhou C
    Arch Virol; 2014 Dec; 159(12):3269-78. PubMed ID: 25078390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel influenza polymerase PB2 inhibitors using virtual screening approach and molecular dynamics simulation analysis of active compounds.
    Xu L; Zhao L; Che J; Zhang Q; Cao R; Li X
    Bioorg Med Chem; 2021 Dec; 52():116515. PubMed ID: 34839161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses.
    Park JG; Ávila-Pérez G; Nogales A; Blanco-Lobo P; de la Torre JC; Martínez-Sobrido L
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
    Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C
    Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and in vitro biological evaluation of novel 6-methyl-7-substituted-7-deaza purine nucleoside analogs as anti-influenza A agents.
    Lin C; Sun C; Liu X; Zhou Y; Hussain M; Wan J; Li M; Li X; Jin R; Tu Z; Zhang J
    Antiviral Res; 2016 May; 129():13-20. PubMed ID: 26802557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus.
    Lejal N; Tarus B; Bouguyon E; Chenavas S; Bertho N; Delmas B; Ruigrok RW; Di Primo C; Slama-Schwok A
    Antimicrob Agents Chemother; 2013 May; 57(5):2231-42. PubMed ID: 23459490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis, Biological Evaluation, and Molecular Dynamics Simulation of Influenza Polymerase PB2 Inhibitors.
    Li X; Xu Y; Li W; Che J; Zhao X; Cao R; Li X; Li S
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-influenza virus activity of a salcomine derivative mediated by inhibition of viral RNA synthesis.
    Takizawa N; Kimura T; Watanabe T; Shibasaki M
    Arch Virol; 2018 Jun; 163(6):1607-1614. PubMed ID: 29497849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.